Research & Innovation
Projects
The Institut de Recerca Sant Pau develops research projects across multiple scientific areas, with the aim of generating innovative knowledge that has an impact on health. Through national and international collaborations, these projects contribute to scientific progress and the improvement of healthcare.
International Grants Unit contact
Active
PNC00465
Ajut infermeriaFeb2026_SaradelValle
Start Date: 2026-02-06
End Date: 2027-12-31
Amount: 4.371,98 €
Funding body: FUNDACIO PRIVADA HOSPITAL DE LA SANTA CREU I SANT PAU
Active
PNC00464
Ajut infermeriaFeb2026_ArnauSamon
Start Date: 2026-02-06
End Date: 2027-12-31
Amount: 9.908,00 €
Funding body: FUNDACIO PRIVADA HOSPITAL DE LA SANTA CREU I SANT PAU
Active
PCI00372
ALZSI-26-1649318: Genetically determined Alzheimer's Disease: Research Advances in Down Syndrome & Autosomal Dominant Alzheimer's Disease Conference 2026
Start Date: 2026-02-01
End Date: 2026-09-30
Amount: 34.255,61 €
Funding body: ALZHEIMER'S ASSOCIATION
Call title: ALZSI-26-1649318
Active
CIP-TLEL-25
Estudio de seguimiento clínico poscomercialización del sistema de transporte óseo transversal TrueLok Elevate para el tratamiento de úlceras de las extremidades inferiores como defectos de partes blandas
Start Date: 2026-02-01
End Date: 2028-04-30
Amount: 0,00 €
Active
PDC2025-165867-I00
Targeting DNA damage response in cancer therapeutics using the synthetic lethality approach.
Start Date: 2026-02-01
End Date: 2028-01-31
Amount: 278.300,00 €
Funding body: MIN.CIENCIA, INNOV.I UNIV.
Call title: Proyectos de prueba de concepto 2025
Active
109
Implicación de NOR-1 en la hipertrofia cardíaca fisiológica
Start Date: 2026-01-23
End Date: 2031-01-23
Amount: 0,00 €
Active
Acuerdo 193
PLAN DE PUBLICACIONES DE LA UNIDAD FUNCIONAL DE HEPATOCARCINOMA DEL HOSPITAL DE LA SANTA CREU I SANT PAU DE BARCELONA – GRUPO DE INVESTIGACIÓN EN ONCOLOGÍA CLÍNICADE LA FUNDACIÓ INSTITUT DE RECERCA DE L’HOSPITAL DE LA SANTA CREU I SANT PAU
Start Date: 2026-01-19
End Date: 2027-07-19
Amount: 11.500,00 €
Funding body: ROCHE FARMA, SA
Active
INN00119
Outcome Measure User License Agreement_for clinical CIDP assesment
Start Date: 2026-01-16
End Date: 2027-01-16
Amount: 0,00 €